Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04509206 · ClinicalTrials.gov registry record · NA

Virtual Teaching Kitchen

A NA study of Metabolic Syndrome and Cardiac Health, sponsored by Boston University.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT04509206: Completed NA study of Metabolic Syndrome and Cardiac Health, sponsored by Boston University.

NCT04509206 is a NA study of Metabolic Syndrome and Cardiac Health that has completed, run by Boston University. The registered enrollment target is 16 participants, below the 1,205-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04509206, a NA study of Metabolic Syndrome and Cardiac Health, has completed, sponsored by Boston University.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

A novel way of delivering nutritional education is through experiential learning in a teaching kitchen setting. Studies have shown that patients with metabolic syndrome who underwent a series of classes that featured nutrition recommendations and cooking classes had improved cardiac health. Boston Medical Center (BMC) serves many underserved, low-income patients and has developed an innovative strategy to combat food insecurity and its consequences. This includes a preventative food pantry, a teaching kitchen, and a rooftop farm that provides fresh produce directly to the patients. The presence of this well-established three-pronged approach places our institution in an ideal position to develop a nutritional education intervention that supports experiential learning in this high-risk population. Given the increasing focus on providing remote experiences to minimize contact and risk of infection with Sars-COV-2, the investigators are proposing a study where patients can benefit from nutritional education virtually. Patients with food insecurity and metabolic syndrome who utilize the food pantry will be invited to an educational program conducted on zoom. The program will be run by a registered dietician and chef who will deliver education virtually. Data will be collected using surveys, phone interviews, chart review, and home monitoring to test both the feasibility of running such an intervention virtually and to explore whether attending this program improves cardiac health in patients.

Primary Outcome

based on number of people invited to participate, number recruited and consented and number attended

Interventions

  • BEHAVIORAL Nutritional education

Study Locations (1)

Massachusetts

  • Boston Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2020-09-28
Est. Completion 2021-08-13
Phase NA
Boston University

185 total trials

What the finished NCT04509206 record still lists

NCT04509206 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,205-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Metabolic Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Nutritional education is the first listed.

NCT04509206 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04509206 about?

NCT04509206 is a clinical study titled "Virtual Teaching Kitchen". A novel way of delivering nutritional education is through experiential learning in a teaching kitchen setting. Studies have shown that patients with metabolic syndrome who underwent a series of classes that featured nutrition recommendations and cooking classes had improved cardiac health. Boston ...

What is the current status of trial NCT04509206?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2020-09-28. Estimated completion is 2021-08-13.

What conditions does trial NCT04509206 study?

This clinical trial studies the following conditions: Metabolic Syndrome, Cardiac Health.

What interventions are being tested in trial NCT04509206?

The interventions under investigation include: Nutritional education (BEHAVIORAL).

Who is sponsoring clinical trial NCT04509206?

This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04509206 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Metabolic Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04509206's enrollment target sits among peer trials

16 99th of 102 higher than 4 of 102 other Metabolic Syndrome trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Metabolic Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04509206, the US trial registry maintained by the National Library of Medicine. NCT04509206 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.